Quadrant Capital Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-135
| Closed | -$15.7K | – | 1458 |
|
|
2025
Q1 | $15.7K | Hold |
135
| – | – | ﹤0.01% | 2099 |
|
|
2024
Q4 | $11.4K | Hold |
135
| – | – | ﹤0.01% | 2083 |
|
|
2024
Q3 | $12.1K | Hold |
135
| – | – | ﹤0.01% | 2088 |
|
|
2024
Q2 | $10.9K | Hold |
135
| – | – | ﹤0.01% | 2092 |
|
|
2024
Q1 | $10.8K | Hold |
135
| – | – | ﹤0.01% | 2077 |
|
|
2023
Q4 | $10.7K | Sell |
135
-29
| -18% | -$2.31K | ﹤0.01% | 2041 |
|
|
2023
Q3 | $11.5K | Buy |
164
+24
| +17% | +$1.68K | ﹤0.01% | 1938 |
|
|
2023
Q2 | $10.1K | Buy |
140
+5
| +4% | +$359 | ﹤0.01% | 1990 |
|
|
2023
Q1 | $8.33K | Hold |
135
| – | – | ﹤0.01% | 2099 |
|
|
2022
Q4 | $10.4K | Hold |
135
| – | – | ﹤0.01% | 1929 |
|
|
2022
Q3 | $6K | Hold |
135
| – | – | ﹤0.01% | 2056 |
|
|
2022
Q2 | $5K | Buy |
135
+70
| +108% | +$2.59K | ﹤0.01% | 1937 |
|
|
2022
Q1 | $3K | Sell |
65
-142
| -69% | -$6.55K | ﹤0.01% | 2030 |
|
|
2021
Q4 | $8K | Buy |
207
+7
| +4% | +$271 | ﹤0.01% | 1707 |
|
|
2021
Q3 | $7K | Buy |
200
+92
| +85% | +$3.22K | ﹤0.01% | 1736 |
|
|
2021
Q2 | $7K | Sell |
108
-3
| -3% | -$194 | ﹤0.01% | 1709 |
|
|
2021
Q1 | $6K | Buy |
111
+11
| +11% | +$595 | ﹤0.01% | 1699 |
|
|
2020
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 1473 |
|
|
2020
Q3 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 1356 |
|